*NEWS PAGES*
Swine Flu H1N1 Update - Click Here
Bioquell earns top award for work in superbug battle
8:10am Thursday 12th March 2009
ANDOVER company Bioquell has won a prestigious award for its bug-busting technology.
The business has developed revolutionary ‘peroxide vapour’ technology in the battle against Clostridium difficile (C-diff), which has won recognition from the Department of Health and the NHS Purchasing and Supply Agency (PASA).
Its award was for innovative technological concept or new and novel product or technology in controlling C-diff.
Matt Parks, head of Bioquell’s UK healthcare decontamination practice, said: “We are thrilled to have won such a prestigious award following many years of hard work carrying out painstaking superbug eradication research in hospitals around the world.
“Winning this award highlights the importance of Bioquell’s presence within the NHS to help combat the threat posed by hospital acquired infection.”
Bioquell’s fully managed decontamination service was recently showcased as one of only six technologies trialled throughout seven UK hospitals. The trials proved that such a service could easily be implemented as part of a hospital’s infection control regime, offering quick turnaround times in the decontamination of infected areas.
Room Bio-decontamination Service (RBDS) is now operational in New Zealand!
The team at Biodecon have all recently completed an intense RBDS training course run by Bioquell UK engineers. We now have two RBDS suites able to decontaminate any room, building or enclosure. Up to 500m3 in one go!
For further information on this service or to arrange for a demonstration or quote, please don't hesitate to contact us:
Ph: +64 (0)9 442 4025
Mobile: +64 (0)27 217 8875
